AGM/EGMJun 8, 2026, 04:46 PM
Jaguar Health Stockholders Approve Director Election and Stock Issuances
AI Summary
Jaguar Health, Inc. announced that all five proposals submitted at its reconvened 2026 Annual Meeting of Stockholders on June 8, 2026, were approved. Key approvals include the election of a Class II director, ratification of RBSM LLP as auditor, and the issuance of more than 19.99% of the company's common stock to C/M Capital Master Fund, LP under two separate agreements. Stockholders also granted the company discretionary authority to adjourn the meeting if needed to secure sufficient votes for certain proposals.
Key Highlights
- Jaguar Health stockholders approved the election of John Micek III as a Class II director.
- RBSM LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
- Stockholders approved the issuance of over 19.99% of common stock to C/M Capital Master Fund, LP under the ELOC Agreement.
- Approval was granted for the issuance of over 19.99% of common stock to C/M Capital under the Preferred Stock Purchase Agreement.
- The company received stockholder approval to adjourn the meeting if necessary to solicit additional proxies for Proposals 3 and 4.
Price Impact
More from JAGX